Literature DB >> 8012688

Pharmacological analysis of neutrophil chemotactic factor production by leucocytes and roles of PAF in allergic inflammation in rats.

M Watanabe1, Y Arakida, J Tanabe, A Sugidachi, N Hirasawa, S Mue, K Ohuchi.   

Abstract

1. The role of platelet activating factor (PAF) in neutrophil infiltration in air pouch type allergic inflammation in rats was investigated. 2. Neutrophil infiltration into the pouch fluid 8 h after injection of the antigen (azobenzenearsonate-conjugated acetyl bovine serum albumin) solution into the air pouch of immunized rats was inhibited dose-dependently by treatment with PAF antagonists (CV-3988, L-652,731 and Y-24,180) in parallel with the decrease in neutrophil chemotactic activity in the pouch fluid. 3. Four hours after injection of the antigen solution into the air pouch of immunized and non-immunized rats, there was no significant difference between the two groups in the number of total leucocytes, neutrophils, mononuclear cells and eosinophils in the pouch fluid. However, when the infiltrated leucocytes were incubated in medium, chemotactic factor production by leucocytes from immunized rats was greater than that from non-immunized rats. 4. When leucocytes from non-immunized rats were preincubated for various periods in the medium containing 10 or 50 nM of PAF, washed, and further incubated in the medium containing no PAF, chemotactic factor production was not stimulated. 5. The increase in the chemotactic activity in the conditioned medium was not suppressed by the 5-lipoxygenase inhibitor, AA861. In addition, the chemotactic activity in the conditioned medium was not inhibited by the PAF antagonists. 6. Incubation of the infiltrated leucocytes in the medium containing the protein synthesis inhibitor, cycloheximide, inhibited chemotactic factor production in a concentration-dependent manner in parallel with the decrease in uptake of [3H]-leucine into the acid-insoluble fraction of leucocytes. 7. Separation of the chemotactic activity in the conditioned medium by isoelectric focusing revealed that the leucocyte infiltrated into the pouch fluid produce two kinds of factors, viz. leucocyte-derived neutrophil chemotactic factor-i (LDNCF-1) and LDNCF-2 of which pI values are 4-5 and above 8,respectively.8. The results indicate that PAF has no significant role in leucocyte activation to produce chemotactic factors, and that neutrophil chemotactic factors produced by infiltrated leucocytes are not PAF or leukotriene B4 but are produced through a protein synthesis mechanism.9. The mechanism of action of PAF antagonists on neutrophil infiltration into the inflammatory locus is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012688      PMCID: PMC1910020          DOI: 10.1111/j.1476-5381.1994.tb14033.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Azoproteins. II. A spectrophotometric study of the coupling of diazotized arsanilic acid with proteins.

Authors:  M TABACHNICK; H SOBOTKA
Journal:  J Biol Chem       Date:  1960-04       Impact factor: 5.157

3.  Leukotriene B: a potential mediator of inflammation.

Authors:  M J Smith; A W Ford-Hutchinson; M A Bray
Journal:  J Pharm Pharmacol       Date:  1980-07       Impact factor: 3.765

4.  Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.

Authors:  P M e Silva; M A Martins; H C Faria Neto; R S Cordeiro; B B Vargaftig
Journal:  J Pharmacol Exp Ther       Date:  1991-06       Impact factor: 4.030

5.  A possible role of arachidonate metabolism in allergic air pouch inflammation in rats. Anti-inflammatory effect of indomethacin and dexamethasone and the level of prostaglandin E2 in the exudate.

Authors:  K Ohuchi; S Yoshino; K Kanaoka; S Tsurufuji; L Levine
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

6.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.

Authors:  A W Ford-Hutchinson; M A Bray; M V Doig; M E Shipley; M J Smith
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

7.  Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats.

Authors:  K Ohuchi; Y Kamada; L Levine; S Tsurufuji
Journal:  Prostaglandins Med       Date:  1981-11

8.  A role of peripheral leukocytes in vascular permeability and edema formation in air pouch type allergic inflammation in rats.

Authors:  M Omata; M Watanabe; N Hirasawa; S Tsurufuji; S Mue; K Ohuchi
Journal:  J Pharmacobiodyn       Date:  1991-05

9.  Induction of an allergic air-pouch inflammation in rats.

Authors:  S Tsurufuji; S Yoshino; K Ohuchi
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

10.  Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).

Authors:  J O Shaw; R N Pinckard; K S Ferrigni; L M McManus; D J Hanahan
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

View more
  2 in total

1.  Possible roles of protein kinases in neutrophil chemotactic factor production by leucocytes in allergic inflammation in rats.

Authors:  J Tanabe; M Watanabe; S Kondoh; S Mue; K Ohuchi
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

2.  Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages.

Authors:  M Watanabe; M Yamada; S Mue; K Ohuchi
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.